Es gab 50 kürzliche Insider-Transaktionen für Lixte Biotechnology Holdings, Inc. (LIXT), darunter 43 Käufe und 1 Verkauf. Die gesamten Insider-Käufe beliefen sich auf $3.19M und die gesamten Insider-Verkäufe auf $35.85K.
Bedeutende Insider mit kürzlicher Aktivität umfassen Felix Lourdes, Primus Guy Warren, Stazzone Peter. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — LIXT
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2025-12-24 |
Felix Lourdes |
Director |
RSU-Zuteilung |
25,000 |
$4.05 |
$101.25K |
25,000 |
| 2025-12-24 |
Primus Guy Warren |
Director |
RSU-Zuteilung |
25,000 |
$4.05 |
$101.25K |
25,000 |
| 2025-09-01 |
Felix Lourdes |
Director |
Unbekannt |
- |
- |
- |
- |
| 2025-09-01 |
Stazzone Peter |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-09-01 |
Stazzone Peter |
Chief Financial Officer |
RSU-Zuteilung |
50,000 |
$4.45 |
$222.5K |
50,000 |
| 2025-09-01 |
Primus Guy Warren |
Director |
Unbekannt |
- |
- |
- |
- |
| 2025-08-15 |
Sawyer Jason David |
Director |
RSU-Zuteilung |
25,000 |
$3.59 |
$89.75K |
25,000 |
| 2025-08-15 |
Holloway Michael Andrew |
Director |
RSU-Zuteilung |
25,000 |
$3.59 |
$89.75K |
25,000 |
| 2025-07-18 |
Sawyer Jason David |
Director |
Unbekannt |
- |
- |
- |
- |
| 2025-07-18 |
Holloway Michael Andrew |
Director |
Unbekannt |
- |
- |
- |
- |
| 2025-07-03 |
Pursglove Geordan Garrett |
CEO and Chairman of the Board |
RSU-Zuteilung |
350,000 |
$2.83 |
$990.5K |
350,000 |
| 2025-06-30 |
Forman Stephen J. |
Director |
RSU-Zuteilung |
7,754 |
$0.91 |
$7.02K |
7,754 |
| 2025-06-30 |
Brown Regina |
Director |
RSU-Zuteilung |
10,000 |
$0.91 |
$9.05K |
10,000 |
| 2025-06-30 |
Bernards Rene |
Director |
RSU-Zuteilung |
10,000 |
$0.91 |
$9.05K |
10,000 |
| 2025-06-30 |
Yen Yun |
Director |
RSU-Zuteilung |
10,000 |
$0.91 |
$9.05K |
10,000 |
| 2025-06-16 |
Pursglove Geordan Garrett |
CEO and Chairman of the Board |
Unbekannt |
- |
- |
- |
- |
| 2025-03-31 |
Forman Stephen J. |
Director |
RSU-Zuteilung |
5,851 |
$1.21 |
$7.08K |
5,851 |
| 2025-03-31 |
Yen Yun |
Director |
RSU-Zuteilung |
8,777 |
$1.21 |
$10.62K |
8,777 |
| 2025-03-31 |
Brown Regina |
Director |
RSU-Zuteilung |
9,508 |
$1.21 |
$11.5K |
9,508 |
| 2025-03-31 |
Bernards Rene |
Director |
RSU-Zuteilung |
8,045 |
$1.21 |
$9.73K |
8,045 |
| 2025-01-20 |
Forman Stephen J. |
Director |
RSU-Zuteilung |
3,030 |
$2.33 |
$7.06K |
3,030 |
| 2025-01-20 |
Yen Yun |
Director |
RSU-Zuteilung |
4,545 |
$2.33 |
$10.59K |
4,545 |
| 2025-01-20 |
Brown Regina |
Director |
RSU-Zuteilung |
4,924 |
$2.33 |
$11.47K |
4,924 |
| 2025-01-20 |
Bernards Rene |
Director |
RSU-Zuteilung |
4,166 |
$2.33 |
$9.71K |
4,166 |
| 2024-09-30 |
Forman Stephen J. |
Director |
RSU-Zuteilung |
3,858 |
$1.30 |
$5.02K |
3,858 |
| 2024-09-30 |
Yen Yun |
Director |
RSU-Zuteilung |
5,786 |
$1.30 |
$7.52K |
5,786 |
| 2024-09-30 |
Brown Regina |
Director |
RSU-Zuteilung |
6,269 |
$1.30 |
$8.15K |
6,269 |
| 2024-09-30 |
Bernards Rene |
Director |
RSU-Zuteilung |
5,304 |
$1.30 |
$6.9K |
5,304 |
| 2024-07-01 |
Schellens Johannes Henricus Matthias |
Chief Medical Officer |
Veräußerung |
15,000 |
$2.39 |
$35.85K |
- |
| 2024-06-30 |
Forman Stephen J. |
Director |
RSU-Zuteilung |
3,018 |
$2.37 |
$7.15K |
3,018 |
| 2024-06-30 |
Yen Yun |
Director |
RSU-Zuteilung |
4,527 |
$2.37 |
$10.73K |
4,527 |
| 2024-06-30 |
Brown Regina |
Director |
RSU-Zuteilung |
4,904 |
$2.37 |
$11.62K |
4,904 |
| 2024-06-30 |
Bernards Rene |
Director |
RSU-Zuteilung |
4,149 |
$2.37 |
$9.83K |
4,149 |
| 2023-10-03 |
Bernards Rene |
Director |
Informierter Kauf |
5,527 |
$2.51 |
$13.87K |
- |
| 2023-10-03 |
Van Der Baan Bastiaan Jeroen |
President and CEO |
Informierter Kauf |
10,000 |
$2.80 |
$28K |
11,000 |
| 2023-10-03 |
Bernards Rene |
Director |
Informierter Kauf |
5,527 |
$2.51 |
$13.87K |
25,000 |
| 2023-10-02 |
Bernards Rene |
Director |
Informierter Kauf |
4,473 |
$2.29 |
$10.24K |
- |
| 2023-10-02 |
Bernards Rene |
Director |
Informierter Kauf |
4,473 |
$2.29 |
$10.24K |
19,473 |
| 2023-09-26 |
Van Der Baan Bastiaan Jeroen |
President and CEO |
RSU-Zuteilung |
250,000 |
$1.95 |
$487.5K |
250,000 |
| 2023-09-26 |
Van Der Baan Bastiaan Jeroen |
President, CEO & Vice Chairman |
RSU-Zuteilung |
250,000 |
$1.95 |
$487.5K |
250,000 |
| 2023-06-30 |
Van Der Baan Bastiaan Jeroen |
President and CEO |
RSU-Zuteilung |
10,000 |
$5.88 |
$58.8K |
10,000 |
| 2023-06-30 |
Forman Stephen J. |
Director |
RSU-Zuteilung |
10,000 |
$5.88 |
$58.8K |
10,000 |
| 2023-06-30 |
Yen Yun |
Director |
RSU-Zuteilung |
10,000 |
$5.88 |
$58.8K |
10,000 |
| 2023-06-30 |
Brown Regina |
Director |
RSU-Zuteilung |
10,000 |
$5.88 |
$58.8K |
10,000 |
| 2023-06-30 |
Van Der Baan Bastiaan Jeroen |
Director |
RSU-Zuteilung |
10,000 |
$5.88 |
$58.8K |
10,000 |
| 2022-12-30 |
Van Der Baan Bastiaan Jeroen |
Director |
Informierter Kauf |
10,000 |
$4.90 |
$49K |
10,000 |
| 2022-12-30 |
Van Der Baan Bastiaan Jeroen |
Director |
Informierter Kauf |
10,000 |
$0.49 |
$4.9K |
10,000 |
| 2022-12-15 |
Bernards Rene |
Director |
Informierter Kauf |
15,000 |
$0.51 |
$7.65K |
150,000 |
| 2022-12-12 |
Bernards Rene |
Director |
Informierter Kauf |
10,000 |
$0.61 |
$6.1K |
135,000 |
| 2022-12-09 |
Forman Eric |
Vice President and COO |
Informierter Kauf |
1,112 |
$0.63 |
$700.56 |
- |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
